These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29629844)

  • 1. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Ngiwsara L; Svasti J; Koizumi K
    Vasc Med; 2018 Jun; 23(3):201-211. PubMed ID: 29629844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin Suppresses Lymphangiogenesis via NF-κB/HIF-1α Axis Inhibition.
    Prangsaengtong O; Jantaree P; Lirdprapamongkol K; Svasti J; Koizumi K
    Biol Pharm Bull; 2018; 41(11):1659-1666. PubMed ID: 30381665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
    Mu H; Calderone TL; Davies MA; Prieto VG; Wang H; Mills GB; Bar-Eli M; Gershenwald JE
    Am J Pathol; 2012 May; 180(5):2170-81. PubMed ID: 22465753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An arabinogalactan isolated from Cynanchum atratum promotes lymphangiogenesis and lymphatic vessel remodeling to alleviate secondary lymphedema.
    Li N; Ruan M; Chen W; Han Y; Yang K; Xu H; Shi S; Wang S; Wang H; Wang Y; Liang Q
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):133061. PubMed ID: 38866272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS1 inhibits lymphangiogenesis by attenuating phosphorylation of the lymphatic endothelial cell-specific VEGF receptor.
    Inagaki J; Takahashi K; Ogawa H; Asano K; Faruk Hatipoglu O; Cilek MZ; Obika M; Ohtsuki T; Hofmann M; Kusachi S; Ninomiya Y; Hirohata S
    Exp Cell Res; 2014 May; 323(2):263-75. PubMed ID: 24631293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells.
    Wang TM; Chen CJ; Lee TS; Chao HY; Wu WH; Hsieh SC; Sheu HH; Chiang AN
    J Nutr Biochem; 2011 Feb; 22(2):187-94. PubMed ID: 20573493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E; Rosca EV; Pandey NB; Popel AS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1812-21. PubMed ID: 21920451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.
    Yang Y; Gao Z; Ma Y; Teng H; Liu Z; Wei H; Lu Y; Cheng X; Hou L; Zou X
    Oncotarget; 2016 Jun; 7(25):38025-38035. PubMed ID: 27203545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.
    Wang J; Ma Y; Yang J; Jin L; Gao Z; Xue L; Hou L; Sui L; Liu J; Zou X
    J Cell Mol Med; 2019 Mar; 23(3):2219-2229. PubMed ID: 30648805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
    Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
    Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression.
    Wu YH; Chuang SY; Hong WC; Lai YJ; Chang YL; Pang JH
    J Ethnopharmacol; 2012 Mar; 140(1):55-63. PubMed ID: 22226975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.